Literature DB >> 12531905

Evidence for CD4-enchanced signaling through the chemokine receptor CCR5.

Robert Staudinger1, Sanjay K Phogat, Xiaodong Xiao, Xiahong Wang, Dimiter S Dimitrov, Susan Zolla-Pazner.   

Abstract

The chemokine receptor CCR5 is constitutively associated with the T cell co-receptor CD4 in plasma cell membranes, but the physiological role of this interaction has not been elucidated. Here we show that detergent-solubilized, purified CCR5 can directly associate with purified soluble fragments of the extracellular portion of CD4. We further demonstrate that the physical association of CCR5 and CD4 in membrane vesicles results in the formation of a receptor complex that exhibits macrophage inflammatory protein 1beta (MIP-1beta) binding properties that are distinct from CCR5. The affinity of the CD4-CCR5 complex for MIP-1beta was 3.5-fold lower than for CCR5, but the interaction of CD4 and CCR5 resulted in a receptor complex that exhibited enhanced G-protein signaling as compared with CCR5 alone. MIP-1beta-induced G-protein activation was further increased by simultaneous stimulation of CD4 with its natural agonist, interleukin-16. Thus, the physical association of CD4 and CCR5 results in receptor cross-talk with allosteric CD4-dependent regulation of the binding and signaling properties of CCR5. Although the precise physiological role of the CD4 effects on CCR5-mediated signaling remains unknown, one can speculate that the cross-talk is a component of mechanisms involved in the fine tuning of immune system cell responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531905     DOI: 10.1074/jbc.M212013200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Modulation of chemokine receptor activity through dimerization and crosstalk.

Authors:  C L Salanga; M O'Hayre; T Handel
Journal:  Cell Mol Life Sci       Date:  2009-04       Impact factor: 9.261

2.  Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model.

Authors:  S L-F Pender; V Chance; C V Whiting; M Buckley; M Edwards; R Pettipher; T T MacDonald
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

3.  Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles.

Authors:  Miroslaw K Gorny; Leonidas Stamatatos; Barbara Volsky; Kathy Revesz; Constance Williams; Xiao-Hong Wang; Sandra Cohen; Robert Staudinger; Susan Zolla-Pazner
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120.

Authors:  Navid Madani; Arne Schön; Amy M Princiotto; Judith M Lalonde; Joel R Courter; Takahiro Soeta; Danny Ng; Liping Wang; Evan T Brower; Shi-Hua Xiang; Young Do Kwon; Chih-Chin Huang; Richard Wyatt; Peter D Kwong; Ernesto Freire; Amos B Smith; Joseph Sodroski
Journal:  Structure       Date:  2008-11-12       Impact factor: 5.006

5.  Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism.

Authors:  Craig Meagher; Josh Beilke; Guillermo Arreaza; Qing-Sheng Mi; Wei Chen; Konstantin Salojin; Noah Horst; William W Cruikshank; Terry L Delovitch
Journal:  Diabetes       Date:  2010-08-06       Impact factor: 9.461

6.  Experimental Andes virus infection in deer mice: characteristics of infection and clearance in a heterologous rodent host.

Authors:  Jessica R Spengler; Elaine Haddock; Don Gardner; Brian Hjelle; Heinz Feldmann; Joseph Prescott
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

Review 7.  Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors.

Authors:  Ponraj Prabakaran; Antony S Dimitrov; Timothy R Fouts; Dimiter S Dimitrov
Journal:  Adv Pharmacol       Date:  2007

8.  The Transmembrane Adaptor Protein LIME Is Essential for Chemokine-Mediated Migration of Effector T Cells to Inflammatiory Sites.

Authors:  Inyoung Park; Myoungsun Son; Eunseon Ahn; Young-Woong Kim; Young-Yun Kong; Yungdae Yun
Journal:  Mol Cells       Date:  2020-11-30       Impact factor: 5.034

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.